Cambridge, United States
Apple Tree Partners supports seasoned entrepreneurs in establishing biotech and medical device ventures through its management of two venture capital funds, which have a collective value of $135 million. ATP primarily focuses on proprietary products and technologies that can target markets with unfulfilled requirements. Although their preference is to initiate startups, ATP collaborates with assets of all developmental phases.
34
Total Investments
20
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Apple Tree Partners
Recent Investments (34)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Dec 2023 | |
| Series A | •••••• | Nov 2023 | |
| Series A | •••••• | Aug 2023 | |
| Series A | •••••• | May 2023 | |
| Series A | •••••• | Jan 2023 | |
•••• ••••
|
Series A | •••••• | Oct 2022 |
|
•••• ••••
|
Series B | •••••• | Sep 2022 |
|
•••• ••••
|
Series A | •••••• | Dec 2021 |
|
•••• ••••
|
Series B | •••••• | Nov 2021 |
|
•••• ••••
|
Series A | •••••• | Oct 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
